5 Biotech Penny Stocks To Watch In September 2020

Which Biotech Penny Stocks Are Trending Right Now?

Top Mushroom Penny Stocks To Watch In September 2020

Should Mushroom Stocks Be Part Of Your Strategy In 2020?

Revive Therapeutics Enters into Clinical Trial Agreement to Evaluate Psilocybin for the Treatment of Methamphetamine Use Disorder

TORONTO, Sept. 02, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…

4 Coronavirus Penny Stocks To Watch For September 2020

Are Coronavirus Penny Stocks On Your List This Month?

Revive Therapeutics Announces IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19

TORONTO, Aug. 31, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…

3 Penny Stocks To Watch As Health Care Sector Surges

These Penny Stocks Have Experienced A Strong Uptrend Recently

Revive Therapeutics Announces Submission of IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19

Revive to also explore FDA Expanded Access Program (Compassionate Use) for Bucillamine in COVID-19

Are These Coronavirus Penny Stocks On Your List Right Now?

3 Coronavirus Penny Stocks To Watch Before September We’re winding down another…

Revive Therapeutics to Expand Phase 3 Clinical Trial for Bucillamine in COVID-19 in Asia-Pacific and Canada

TORONTO, Aug. 19, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…

Revive Therapeutics Signs MOU with Attwill Medical Solutions for Phase 3 Clinical Trial for Bucillamine in COVID-19

TORONTO, Aug. 14, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…